SCHEMBL3920907

SCHEMBL3920907

O=c1[nH]c2ncnc(N3CCC(NCc4cccc(Cl)c4)CC3)c2[nH]1.O=c1[nH]c2ncnc(N3CCC(NCc4ccccc4Cl)CC3)c2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT2 P31751 5/20 0.49
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
BACE1 P56817 1/20 0.42
CARM1 Q86X55 1/20 0.41
PRMT6 Q96LA8 1/20 0.41
AKT1 P31749 1/20 0.41
PAK1 Q13153 1/20 0.40
CXCR4 P61073 1/20 0.39
KIT P10721 3/20 0.39
STK4 Q13043 2/20 0.39
STK3 Q13188 2/20 0.39
LRRK2 Q5S007 2/20 0.39
GRM2 Q14416 2/20 0.39
GRM3 Q14832 2/20 0.39
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
TACR1 P25103 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1003089 0.93 AKT2 (0.51) AKT2CARM1PRMT6AKT1PAK1
SCHEMBL1001627 0.91 AKT2 (0.50) AKT2BCHEACHEBACE1AKT1
SCHEMBL3925055 0.87 BCHE (0.41) AKT2BCHEACHEBACE1CARM1
SCHEMBL1002065 0.76 AKT2 (0.46) AKT2AKT1PAK1KIT
SCHEMBL4117984 0.70 AKT2 (0.48) AKT2STK3LRRK2
SCHEMBL4071053 0.69 STAT3 (0.57) AKT2
SCHEMBL3918670 0.69 AKT2 (0.46) AKT2LRRK2
SCHEMBL4124143 0.69 STAT3 (0.55) AKT2KITSTK3
SCHEMBL3916263 0.69 AKT2 (0.59) AKT2KIT
SCHEMBL3919145 0.68 AKT2 (0.46) AKT2AKT1STK3LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2037931-A2 PHARMACEUTICAL COMBINATIONS OF PK INHIBITORS AND OTHER ACTIVE AGENTS Astex Therapeutics Limited (GB) 2009-03-25 EP disclosed
WO-2007125310-A2 PHARMACEUTICAL COMBINATIONS OF PK INHIBITORS AND OTHER ACTIVE AGENTS ASTEX THERAPEUTICS LIMITED (GB) 2007-11-08 WO disclosed